Venrock Fact Sheet

Venrock is a premier venture capital firm with offices in Palo Alto, New York, Cambridge, MA, and Israel.  Originally established as the venture capital arm of the Rockefeller family, Venrock continues an eight-decade tradition of partnering with entrepreneurs to establish successful, enduring companies.  Having invested $2.5 billion in 442 companies resulting in 125 IPOs and 128 M&A exits over the past 41 years, Venrock's investment returns place it among the top tier venture capital firms that have achieved consistently superior performance.  With a primary focus on technology, healthcare, and energy, portfolio companies have included Adify, Adnexus Therapeutics, Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Ironwood, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu. 

Print Version

Venrock entrepreneurs have charted new advancements in cancer therapies.

"Venrock really understands what it takes to build an exceptionally successful biotech company:  great people, novel and often under appreciated technology, a clear vision for company strategy and differentiation, a highly ethical approach to business, and patient capital.  And with Venrock, that patient capital is leveraged by their thoughtful mentoring and coaching of management teams -- truly added-value venture capital at its best."
Photo
William Rastetter, Ph.D., former Chairman and CEO, IDEC Pharmaceuticals.
     
Web design and development by Tenrec, Inc.